drugset / Trial / NCT03825939

Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty

NCT03825939 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research study aims to study the use of tranexamic acid (TXA) in total joint replacement (arthroplasty) of the hip (THR) and knee (TKR).

Timeline

Start
2015-04-21
Primary completion
2016-07-26
Completion
2016-09-06

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of patient enrollment due to only one surgeon that was enrolling.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.